A Single Center Clinical Evaluation of Same Sitting Hybrid Revascularization: Robotic Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention for the Treatment of Coronary Artery Disease

The study population will consist of patients with multivessel coronary artery disease requiring CABG with suitable anatomy for combination CABG and PCI of non-bypassed arteries.

The primary endpoint of this feasibility study is a 30-day composite of major adverse clinical events including death, repeat revascularization, stroke and/or myocardial infarction.

The secondary endpoints include:

• Successful completion of same sitting CABG and coronary stent procedure
• Successful completion of CABG and PCI during single hospitalization
• Achievement of complete revascularization
• Patency of the LIMA and stented vessels as determined by coronary angiography at time of procedures or prior to discharge and by cardiac Computed Tomographic Angiography (CTA) or coronary angiography at 1 year.
• Stent thrombosis at 24 hours (acute), 30 days (sub acute), and 1 year (late)
• One-year composite clinical event endpoints of major clinical events including death, repeat revascularization, myocardial infarction, and freedom from angina
• Comparative analysis of hospital, 30 day, and 1 year events of hybrid CABG patients compared to consecutive patients undergoing off pump CABG with standard thoracotomy during study period

Inclusion criteria

• Requirement for CABG
• Anatomy and body habitus suitable for Robotic CABG
• Requirement of revascularization of arteries amendable for PCI but not accessable by Robotic CABG

Exclusion criteria

• Need for emergent CABG